Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 52,775 | 65,675 | 57,102 | 59,518 | 45,736 |
| Cost of Goods | 13,218 | 16,836 | 12,495 | 14,918 | 10,844 |
| Gross Profit | 39,557 | 48,839 | 44,607 | 44,600 | 34,892 |
| Operating Expenses | 35,410 | 39,659 | 42,709 | 33,460 | 36,483 |
| Operating Income | 4,365 | 10,016 | 2,393 | 12,058 | -747 |
| Interest Expense | 3,312 | 3,279 | 2,947 | 2,702 | 2,664 |
| Other Income | 495 | -12,049 | 261 | 72 | 45 |
| Pre-tax Income | 1,548 | -5,312 | -293 | 9,428 | -3,366 |
| Income Tax | 147 | 294 | 67 | 57 | 37 |
| Net Income Continuous | 1,401 | -5,606 | -360 | 9,371 | -3,403 |
| Net Income | $1,401 | $-5,606 | $-360 | $9,371 | $-3,403 |
| EPS Basic Total Ops | 0.03 | -0.12 | -0.01 | 0.21 | -0.08 |
| EPS Basic Continuous Ops | 0.03 | -0.12 | -0.01 | 0.21 | -0.08 |
| EPS Diluted Total Ops | 0.03 | -0.12 | -0.01 | 0.21 | -0.08 |
| EPS Diluted Continuous Ops | 0.03 | -0.12 | -0.01 | 0.21 | -0.08 |
| EBITDA(a) | $7,243 | $12,469 | $4,862 | $14,519 | $1,710 |